RESI@TMCX: Hear From Large Pharma Sourcing Execs First Hand

16 Jul

By Michael Quigley, Director of Research, LSN

mike-2The Large Pharma Panel at RESI is always one of the most popular and RESI@TMCx was no exception. This panel featuring representatives from Johnson and Johnson, Boehringer Ingelheim, Bristol Myers Squibb, Takeda Ventures, and Sanofi discusses the specific areas where these groups are looking to make allocations and how companies should go about getting on their radar. Other topics addressed include why big pharma is looking early stage and how big pharma looks to partner with big medtech and foundations/venture philanthropy groups to move science forward.

To hear firsthand big pharma’s opinion on these topics, watch this RESI video recap.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: